Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Sells]

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $13.70 (-7.4%) * Over Last 12-Mos
Rating Score: 4 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/6/2014 Cantor Fitzgerald Downgrade Sell
(Hold)
10.00
(11.00)
12.59 14.79 17.47% Details
9/17/2013 Goldman Sachs New Coverage Sell
(N/A)
9.50
(N/A)
13.64 14.79 8.43% Details
Like IRWD Ratings? Also take a look at SGYP, ACT, FRX, KERX

IRWD Ratings News